George Matcham
Director/Board Member chez INSTIL BIO, INC.
Fortune : 19 586 $ au 31/03/2024
Profil
George Matcham currently works at Instil Bio, Inc., as Independent Director from 2018.
Dr. Matcham also formerly worked at Chimeric Therapeutics Ltd.
(Australia), as Non-Executive Director from 2021 to 2023, Celgene Corp., as SVP-CAR T CMC & Technology Development from 2017 to 2018, and Celgene Cellular Therapeutics, as Chief Operating Officer.
Dr. Matcham received his graduate degree from the University of Cambridge and undergraduate degree and doctorate degree from the University of Cardiff.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/09/2023 | 1 000 800 ( 0,12% ) | 19 586 $ | 31/03/2024 | |
INSTIL BIO, INC.
-.--% | 14/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de George Matcham
| Sociétés | Poste | Début |
|---|---|---|
| INSTIL BIO, INC. | Director/Board Member | 01/09/2018 |
Anciens postes connus de George Matcham
| Sociétés | Poste | Fin |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Director/Board Member | 03/08/2023 |
| CELGENE | Corporate Officer/Principal | 01/06/2018 |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The private company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Chief Operating Officer | - |
Formation de George Matcham
| University of Cambridge | Graduate Degree |
| University of Cardiff | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The private company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Health Technology |
| Instil Bio, Inc. | |
| Chimeric Therapeutics Ltd. (Australia) |
